The Technical Analyst
Select Language :
Jaguar Health Inc [JAGX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Jaguar Health Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Jaguar Health Inc is listed at the  Exchange

23.32% $0.0899

America/New_York / 28 mar 2024 @ 16:00


Jaguar Health Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 18.59 mill
EPS: -0.870
P/E: -0.100
Earnings Date: Apr 01, 2024
SharesOutstanding: 206.76 mill
Avg Daily Volume: 37.83 mill
RATING 2024-03-28
A-
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Strong Buy
P/E: Neutral
Price To Book: Strong Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.100 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.02x
Company: PE -0.100 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.0699 - 0.110

( +/- 22.25%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-08-14 Jayasuriya Anula Buy 68 568 Common Stock
2023-07-01 Jayasuriya Anula Buy 1 718 Common Stock
2023-07-01 Jayasuriya Anula Sell 1 718 Restricted stock units
2023-08-14 Siegel Jonathan B. Buy 68 568 Common Stock
2023-08-14 Micek John Buy 68 568 Common Stock
INSIDER POWER
80.36
Last 99 transactions
Buy: 5 141 574 | Sell: 492 412

Forecast: 16:00 - $0.0866

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.0866
Forecast 2: 16:00 - $0.0866
Forecast 3: 16:00 - $0.0866
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.0899 (23.32% )
Volume 58.42 mill
Avg. Vol. 37.83 mill
% of Avg. Vol 154.43 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Jaguar Health Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Jaguar Health Inc

RSI

Intraday RSI14 chart for Jaguar Health Inc

Last 10 Buy & Sell Signals For JAGX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Jaguar Health Inc

JAGX

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for short bowel syndrome with intestinal failure with; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops lechlemer, a second-generation anti-secretory agent for cholera; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.

Last 10 Buy Signals

Date Signal @
FLIPUSDMar 29 - 10:055.04
SCNSOLUSDMar 29 - 09:59220.06
INVUSDMar 29 - 09:5963.18
SUPERUSDMar 29 - 09:34$1.359
UQCUSDMar 29 - 06:54$7.20
BNBUSDMar 29 - 09:31$615.19
TIMEUSDMar 29 - 09:3232.37
AGLDUSDMar 29 - 09:301.650
MINAUSDMar 29 - 09:29$1.238
CBKUSDMar 29 - 09:281.087

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.